Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing.
about
Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes.Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies.Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.
P2860
Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Upgrading HepG2 cells with ade ...... r drug hepatotoxicity testing.
@en
type
label
Upgrading HepG2 cells with ade ...... r drug hepatotoxicity testing.
@en
prefLabel
Upgrading HepG2 cells with ade ...... r drug hepatotoxicity testing.
@en
P2860
P1476
Upgrading HepG2 cells with ade ...... r drug hepatotoxicity testing.
@en
P2093
M José Gómez-Lechón
P2860
P304
P356
10.1080/17425255.2017.1238459
P407
P577
2016-09-27T00:00:00Z